RAPA/MET‐treatment counteracted the effect that RAPA‐treatment alone had on G6pc expression, restoring a more normal ratio with Gsk, and it prevented the specific hyperglycemia that was associated with RAPA‐treatment. This evidence concerns the gene G6PC1 and Hyperglycemia.